February 17, 2026
By:
Bryan O’Sullivan
Clinical Research Specialist
The landscape of metabolic medicine is shifting at a quantum pace. What began with the quiet introduction of once-weekly GLP-1 agonists for diabetes has erupted into a nationwide conversation about drug affordability, healthy weight loss, and whether “body positivity” even has a place in a post-Ozempic world. It is a class of drugs that has spread with a virality rivaled only by—and often boosted by—the Kardashians.
Now, with the “triple agonist” retatrutide on the horizon, we are entering the next phase of the peptide revolution. At Velocity Health, our response to this noise, and our response to members who are interested in what peptides can do for them, is a cautious, nuanced implementation strategy. We don’t view peptides as “miracle shots,” but as potent biological levers. As the receptor complexity increases from single to dual to triple agonism, so do the stakes. Our approach remains rooted in the “N of 1” philosophy; we make sure that each of our health interventions is the right tool for the right person at the right time. And we always employ the appropriate monitoring, follow-up, and adjunct nutrition and resistance training.
To understand where we are going, we have to understand the specific biological “buttons” we are pushing.
A Balanced Analysis:
Benefits Beyond the Scale
A Balanced Analysis: Benefits Beyond the Scale
The headlines focus on the 24% weight loss seen in retatrutide’s Phase 2 trials—a figure that rivals bariatric surgery. However, at Velocity, we look for the “Metabolic Fitness” these agents foster beyond the number on the scale:
As we move toward the availability of triple agonism, we must consider some of the potential consequences of the robust weight loss that many people yearn for with these agents. Potency comes with a price.
Rapid weight loss without strict adherence to high-protein intake and resistance training leads to the loss of lean muscle mass. If you lose 30 pounds, but 15 pounds of that is muscle, you haven’t gotten any healthier. Instead, you’ve just become more frail. At Velocity, we view baseline DEXA scans and regular body composition monitoring as non-negotiable. And both ensuring sufficient dietary protein intake (generally at least 1g protein/lb of body weight) and following a structured resistance training program are also critical to ensure patients experience healthy weight loss that does not drive muscle wasting and frailty.
One of our guiding principles when it comes to the use of any pharmaceutical intervention is “minimum viable dose.” Flooding receptors with supratherapeutic levels of triple agonists too early may lead to receptor down-regulation. There is a strategic argument for starting with a single agonist at the lowest effective dose, increasing the dosage slowly, and “stepping up” to dual or triple agents only when metabolic parameters plateau, rather than using the most potent tool as a first-line option. And while these agents are often used in patients “for life,” we prefer to cycle patients off where possible to minimize pharmacological burden and resort to these potent tools only when necessary.
While GI side effects (nausea, gastroparesis) are well-documented, the addition of glucagon (the third “G”) introduces new variables. We are still learning how chronic glucagon agonism affects long-term basal metabolic rate and whether it increases the risk of “rebound” weight gain if a patient does not have a clear, structured off-ramp plan.
The Velocity Framework:
Precision Over Sensationalism
In a landscape often split between euphoric enthusiasm and fear-mongering, Velocity chooses the middle path. Instead of doling out weight loss therapies like a peptide vending machine, we work with you to optimize your health and achieve your wellness goals. Our framework ensures every health intervention is vetted for:
The arrival of triple agonists represents a massive upgrade to our arsenal of metabolic-disease-fighting tools. But these are just tools, not crutches. True longevity is found when cutting-edge therapeutics are used as an adjunct to a healthy foundation of good sleep, nutrition, physical activity, and stress modulation.
We are excited about the data, but we remain fiercely committed to the “N of 1” journey: ensuring that your pursuit of weight loss never comes at the expense of your long-term vitality.
Experience the
future of health
